Saphenion: Deutsche VenaSeal® – MulticenterStudie

Saphenion: Deutsche VenaSeal® – MulticenterStudie

Saphenion: Deutsche VenaSeal® – MulticenterStudie: Wir haben es getan, wir haben uns telefonisch ausgetauscht, wir haben uns getroffen, anlässlich der Bonner Venentage im Februar 2020, haben uns geschrieben und waren uns schnell einig. Wir wollten eine erste deutsche MulticenterStudie zur Krampfadertherapie mit dem Venenkleber „VenaSeal®“ erstellen. Mit der Erfahrung von über 8 Jahren Anwendung, mit 2988 therapierten Patienten und 5333 Stammkrampfadern als Grundlage unserer Erfahrungen. Diese Erfahrungen und Daten sind in ihrer Dimension bisher in der Wissenschaft weltweit einmalig.

Saphenion: Deutsche VenaSeal® – MulticenterStudie: Am 20.11.2020 haben wir den Entwurf unserer angenommenen Arbeit erhalten. Da stellt sich schon ein wenig Stolz ein und grosse Dankbarkeit den Kollegen, die dabei waren; Dr. Jörg Fuchs aus Köln, Dr. Joachim Thum aus Hildesheim und Dr. Christoph Bernhard aus München zusammen mit den Saphenion® Venenzentren Berlin und Rostock. Dank an Euch Alle und besonders an Jörg Fuchs, der den Bleistift führte…

Saphenion: German VenaSeal® – a multicenter study

Saphenion: German VenaSeal® multicenter study: We did it, we exchanged views over the phone, we met, on the occasion of the Bonn Vein Days in February 2020, wrote to each other and quickly came to an agreement. We wanted to create a first German multicenter study on varicose vein therapy with the vein glue „VenaSeal®“. With the experience of over 8 years of use, with 2988 treated patients and 5333 truncal varicose veins as the basis of our experience. These experiences and data are unique in their dimensions in science worldwide.

And on November 20, 2020, we received the draft of our accepted work. There is a little pride and great gratitude to the colleagues who were there; Dr Jörg Fuchs from Cologne, Dr Joachim Thum from Hildesheim and Dr Christoph Bernhard from Munich together with the Saphenion® Vein Centers Berlin and Rostock. Thanks to all of you and especially to Jörg Fuchs, who kept the pencil …

Papers / Links:

Gibson K, Morrison N, Kolluri R, Vasquez M, Weiss R, Cher D, Madsen M, Jones A. Twenty-four month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2018 Sep;6(5):606-613. doi: 10.1016/j.jvsv.2018.04.009. Epub 2018 Jun 15. PMID: 29914814.

Morrison N, Gibson K, Vasquez M, Weiss R, Jones A. Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):978-989. doi: 10.1016/j.jvsv.2019.12.080. Epub 2020 Mar 20. PMID: 32205125.

Morrison N, Gibson K, McEnroe S, Goldman M, King T, Weiss R, Cher D, Jones A. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015 Apr;61(4):985-94. doi: 10.1016/j.jvs.2014.11.071. Epub 2015 Jan 31. PMID: 25650040.

Kolluri R, Gibson K, Cher D, Madsen M, Weiss R, Morrison N. Roll-in phase analysis of clinical study of cyanoacrylate closure for incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2016 Oct;4(4):407-15. doi: 10.1016/j.jvsv.2016.06.017. Epub 2016 Aug 8. PMID: 27638993.

Boersma D, Kornmann VN, van Eekeren RR, Tromp E, Ünlü Ç, Reijnen MM, de Vries JP. Treatment Modalities for Small Saphenous Vein Insufficiency: Systematic Review and Meta-analysis. J Endovasc Ther. 2016 Feb;23(1):199-211. doi: 10.1177/1526602815616375. Epub 2015 Nov 12. PMID: 26564912.

Cho S, Park HS, Lee T, Byun SJ, Yun WS, Yang SS, Kim H, Kim WS, Joh JH, Jung IM. CASS (CyanoAcrylate closure versus Surgical Stripping for incompetent saphenous veins) study; a randomized controlled trial comparing clinical outcomes after cyanoacrylate closure and surgical stripping for the treatment of incompetent saphenous veins. Trials. 2020 Jun 3;21(1):460. doi: 10.1186/s13063-020-04393-0. PMID: 32493398; PMCID: PMC7268719.

Morrison N, Kolluri R, Vasquez M, Madsen M, Jones A, Gibson K. Comparison of cyanoacrylate closure and radiofrequency ablation for the treatment of incompetent great saphenous veins: 36-Month outcomes of the VeClose randomized controlled trial. Phlebology. 2019 Jul;34(6):380-390. doi: 10.1177/0268355518810259. Epub 2018 Nov 7. PMID: 30403154; PMCID: PMC6587361.